Royal Bank Of Canada Medicinova Inc Transaction History

Royal Bank Of Canada

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.28 - $1.57 $275 - $337	-215 Reduced 56.58%	165 $0
Q1 2024 Nov 05, 2024	BUY	$1.28 - $1.65 $275 - $354	215 Added 130.3%	380 $0
Q1 2024 May 15, 2024	SELL	$1.28 - $1.65 $600 - $773	-469 Reduced 55.24%	380 $0
Q4 2023 Feb 14, 2024	BUY	$1.38 - $2.06 $1,171 - $1,748	849 New	849 $1,000
Q2 2023 Aug 14, 2023	BUY	$2.09 - $2.43 $604 - $702	289 New	289 $0
Q3 2021 Nov 15, 2021	SELL	$3.4 - $4.24 $2,543 - $3,171	-748 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.76 - $5.14 $2,812 - $3,844	748 New	748 $3,000

4.83M

9.4K

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $106M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.